Augmedix Inc

Augmedix — Investor Presentation (May 2023)

18 slides from Augmedix's investor presentation, May 12, 2023

  1. Slide 1: Investor Presentation May 2023

    Investor Presentation 1 May 2023

  2. Slide 2: Forward-looking statements

    This presentation includes forward - looking statements. All statements other than statements of historical facts contained in these materials or elsewhere, including statements regarding the Company’s future financial position, business strategy and plans and objectives of management for future ope

  3. Slide 3: The Healthcare Dilemma

    3 The Healthcare Dilemma 3 Clinician burnout and chronic staffing shortages are creating a significant gap between health systems’ capacity to provide care and the demand for care from a growing and aging patient population. Today’s point - of - care delivery policies and technologies consume up to

  4. Slide 4: Augmedix Mission & Vision

    Augmedix Mission & Vision 4 Our mission is to help healthcare providers shrink their care gap and increase patient access at scale by unburdening their clinicians from medical documentation so they can redirect more of their time towards patient care. We manage medical documentation virtually and un

  5. Slide 5: Augmedix Benefits

    5 5 Augmedix Benefits Save up to 3 hours per day Boost productivity by as much as 20% 40% improved work - life satisfaction 5

  6. Slide 6: Augmedix at a Glance

    38% YoY Real - time and asynchronous virtual medical documentation for clinicians Connect clinicians with Augmedix Notebuilder Platform through mobile devices and proprietary software Comprehensive and flexible solution capable of being delivered at scale to ~ 295,000 addressable clinicians Let clin

  7. Slide 7: Augmedix Eases the EHR Burden on Providers & Creates System Efficiencies

    Augmedix Eases the EHR Burden on Providers & Creates System Efficiencies Natural Conversation Enhanced Documentation Clinician - Patient Notebuilder Platform Electronic Health Record Medical documentation uploaded for clinician’s sign - off Natural Language Processing (NLP) and Large Language Models

  8. Slide 8: Driving a $6 Billion Market Opportunity for Augmedix

    8 Driving a $6 Billion Market Opportunity for Augmedix ~295,000 ¹ Addressable Clinicians in U.S. $6B U.S. Market Opportunity >57,000 ¹ Addressable Clinicians $1.2B+ Expansion Opportunity within Existing Customers United States India Bangladesh Sri Lanka Opportunity (1) Company estimates out of a tot

  9. Slide 9: Augmedix Has the Broadest Product Portfolio

    9 Augmedix Has the Broadest Product Portfolio Chart prep Prior to start of day RPA AI - powered $ Ambient Documentation Products Draft medical note TAT minutes AI - powered $ Quality - assured medical note TAT 4 hrs AI - powered + Augmedix quality control $$ Asynchronous Synchronous Quality - assure

  10. Slide 10: Well Positioned within Documentation Market

    10 Well Positioned within Documentation Market Dictation/Transcription Asynchronous Documentation Synchronous Documentation Pric e Low SA DAX DAX Express Dragon Fluency Direct Clinician Burden Remote In - Person Remote High Ambient Products Complete Note / Human in the Loop Draft Note / Pure AI

  11. Slide 11: AI / ML Note automation is ultimate goal

    AI / ML Note automation is ultimate goal Lower cost Scalable Standardization Rapid turn - around LLMs alone insufficient: • Encounters rarely follow note format - typically non - linear • Complex conditions often result in errors and “note” bloat • Need to convert conversational language into approp

  12. Slide 12: Notebuilder Platform Drives Efficiency

    12 Ambient conversation Messages Reminders Medical Note Chart Prep Coding ASR+ EHR Integration Augmedix NLP / LLMs Note Engine Builder Manager Building Block approach combines: • automated speech recognition • natural language processing and large language models • Clinical datasets 35+ Specialties

  13. Slide 13: Quality Assured Ambient Conversation to Note Creation

    13 Quality Assured Ambient Conversation Clinician - Patient Transparent Note Creation Notebuilder Canvas Automatic Speech Recognition (ASR) Clinician : Nice to meet you . What brings you in today? Patient: I got a headache yesterday and it just won’t go away. Clinician: Any fever or chills? Patient:

  14. Slide 14: Competitive Differentiation

    14 Transparency User control Structured data Product fungibility Broad care settings Competitive Differentiation

  15. Slide 15: Robust KPI Performance

    15 Robust KPI Performance NRR (1) 125% (2) 43% YoY CIS Growth 41% 43% 49% 53% 1. Based on current period revenue including any expansion or new services and is net of contraction or churn compared to the previous period one year ago, but excludes revenue from new Health Enterprises for the current p

  16. Slide 16: Consistent Strong Growth

    16 Consistent Strong Growth $12M strategic financing, including HCA Healthcare, enables Augmedix to reach cash flow breakeven exiting Q4 2024 Note: Fiscal years are audited through December 31, 2022. Quarterly results are unaudited. (1) Q2 2021 includes one - time benefit from a previous office leas

  17. Slide 17: Highly Experienced Management Team

    Highly Experienced Management Team Sandra Breber Chief Operating Officer Paul Ginocchio Chief Financial Officer Rashed Noman Country Manager, Bangladesh Ian Shakil Co - Founder & Chief Strategy Officer Jonathan Hawkins Chief Revenue Officer Davin Lundquist Chief Medical Officer Saurav Chatterjee Chi

  18. Slide 18: Investment Highlights

    Investment Highlights Broad virtual documentation offerings that are differentiated and flexible across a variety of care settings Increases clinician productivity, optimizes reimbursement and improves patient access Deployed at 5 of top 10 US healthcare enterprises with high Net Revenue Retention A

Augmedix — Investor Presentation (May 2023) on 6ix